rs3204173

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_017955.4(CDCA4):​c.*883A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.788 in 152,554 control chromosomes in the GnomAD database, including 47,575 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.79 ( 47464 hom., cov: 33)
Exomes 𝑓: 0.82 ( 111 hom. )

Consequence

CDCA4
NM_017955.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.03

Publications

5 publications found
Variant links:
Genes affected
CDCA4 (HGNC:14625): (cell division cycle associated 4) This gene encodes a protein that belongs to the E2F family of transcription factors. This protein regulates E2F-dependent transcriptional activation and cell proliferation, mainly through the E2F/retinoblastoma protein pathway. It also functions in the regulation of JUN oncogene expression. This protein shows distinctive nuclear-mitotic apparatus distribution, it is involved in spindle organization from prometaphase, and may also play a role as a midzone factor involved in chromosome segregation or cytokinesis. Two alternatively spliced transcript variants encoding the same protein have been noted for this gene. Two pseudogenes have also been identified on chromosome 1. [provided by RefSeq, May 2014]
CLBA1 (HGNC:20126): (clathrin binding box of aftiphilin containing 1) Predicted to enable clathrin binding activity. Predicted to be involved in intracellular transport. Predicted to be part of AP-1 adaptor complex. Predicted to be active in trans-Golgi network membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.803 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017955.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDCA4
NM_017955.4
MANE Select
c.*883A>G
3_prime_UTR
Exon 2 of 2NP_060425.2
CDCA4
NM_145701.4
c.*357A>G
3_prime_UTR
Exon 3 of 3NP_663747.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDCA4
ENST00000336219.4
TSL:1 MANE Select
c.*883A>G
3_prime_UTR
Exon 2 of 2ENSP00000337226.3
CDCA4
ENST00000392590.3
TSL:1
c.*357A>G
3_prime_UTR
Exon 3 of 3ENSP00000376369.3
CDCA4
ENST00000896959.1
c.*883A>G
3_prime_UTR
Exon 3 of 3ENSP00000567018.1

Frequencies

GnomAD3 genomes
AF:
0.788
AC:
119874
AN:
152112
Hom.:
47433
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.782
Gnomad AMI
AF:
0.726
Gnomad AMR
AF:
0.797
Gnomad ASJ
AF:
0.844
Gnomad EAS
AF:
0.549
Gnomad SAS
AF:
0.711
Gnomad FIN
AF:
0.805
Gnomad MID
AF:
0.880
Gnomad NFE
AF:
0.808
Gnomad OTH
AF:
0.792
GnomAD4 exome
AF:
0.821
AC:
266
AN:
324
Hom.:
111
Cov.:
0
AF XY:
0.785
AC XY:
146
AN XY:
186
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.816
AC:
253
AN:
310
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.917
AC:
11
AN:
12
Other (OTH)
AF:
1.00
AC:
2
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.528
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.788
AC:
119960
AN:
152230
Hom.:
47464
Cov.:
33
AF XY:
0.786
AC XY:
58530
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.782
AC:
32479
AN:
41532
American (AMR)
AF:
0.796
AC:
12174
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.844
AC:
2928
AN:
3468
East Asian (EAS)
AF:
0.548
AC:
2840
AN:
5178
South Asian (SAS)
AF:
0.711
AC:
3431
AN:
4824
European-Finnish (FIN)
AF:
0.805
AC:
8545
AN:
10614
Middle Eastern (MID)
AF:
0.878
AC:
258
AN:
294
European-Non Finnish (NFE)
AF:
0.808
AC:
54973
AN:
68004
Other (OTH)
AF:
0.791
AC:
1671
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1328
2655
3983
5310
6638
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
872
1744
2616
3488
4360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.801
Hom.:
41562
Bravo
AF:
0.786
Asia WGS
AF:
0.601
AC:
2096
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.61
DANN
Benign
0.23
PhyloP100
-1.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3204173; hg19: chr14-105476658; API